DE69423753D1 - Polyoximverbindungen und deren herstellung - Google Patents
Polyoximverbindungen und deren herstellungInfo
- Publication number
- DE69423753D1 DE69423753D1 DE69423753T DE69423753T DE69423753D1 DE 69423753 D1 DE69423753 D1 DE 69423753D1 DE 69423753 T DE69423753 T DE 69423753T DE 69423753 T DE69423753 T DE 69423753T DE 69423753 D1 DE69423753 D1 DE 69423753D1
- Authority
- DE
- Germany
- Prior art keywords
- baseplate
- polyoxime
- production
- organic molecules
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5759493A | 1993-05-05 | 1993-05-05 | |
US08/114,877 US6174530B1 (en) | 1993-05-05 | 1993-08-31 | Homogeneous polyoxime compositions and their preparation by parallel assembly |
US08/105,904 US6001364A (en) | 1993-05-05 | 1993-08-31 | Hetero-polyoxime compounds and their preparation by parallel assembly |
PCT/IB1994/000093 WO1994025071A1 (en) | 1993-05-05 | 1994-05-05 | Polyoxime compounds and their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69423753D1 true DE69423753D1 (de) | 2000-05-04 |
DE69423753T2 DE69423753T2 (de) | 2000-11-02 |
Family
ID=27369284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69423753T Expired - Fee Related DE69423753T2 (de) | 1993-05-05 | 1994-05-05 | Polyoximverbindungen und deren herstellung |
Country Status (11)
Country | Link |
---|---|
US (1) | US6663869B1 (de) |
EP (1) | EP0697891B1 (de) |
JP (1) | JP3734828B2 (de) |
AT (1) | ATE191148T1 (de) |
AU (1) | AU686153B2 (de) |
CA (1) | CA2162157A1 (de) |
DE (1) | DE69423753T2 (de) |
DK (1) | DK0697891T3 (de) |
ES (1) | ES2146649T3 (de) |
GR (1) | GR3033699T3 (de) |
PT (1) | PT697891E (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060026011A (ko) * | 2003-05-09 | 2006-03-22 | 노보 노르디스크 에이/에스 | 비만 치료용 펩티드 |
BRPI0409976A (pt) * | 2003-05-09 | 2006-05-09 | Novo Nordisk As | composto, métodos para retardar a progressão de igt diabetes do tipo 2, para retardar a progressão de diabetes do tipo 2 para diabetes que requer insulina, para tratar obesidade ou prevenir excesso de peso para regular o apetite para induzir saciedade, para prevenir ganho de peso após se ter tido sucesso em perder peso, para aumentar dispêndio de energia, para tratar uma doença ou estado e para tratar bulimia, composição farmacêutica, e, uso de um composto |
RU2008100218A (ru) * | 2005-07-18 | 2009-08-27 | Ново Нордикс А/С (Dk) | Пептиды для лечения ожирения |
US8795680B2 (en) * | 2006-07-21 | 2014-08-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid |
EP2104684A1 (de) * | 2007-01-18 | 2009-09-30 | Novo Nordisk A/S | Peptide zur verwendung bei der behandlung von adipositas |
JP2010516652A (ja) * | 2007-01-18 | 2010-05-20 | ノボ・ノルデイスク・エー/エス | 肥満の治療に使用される新規ペプチド |
US20100022446A1 (en) * | 2007-01-18 | 2010-01-28 | Novo Nordisk A/S | Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity |
JP5702150B2 (ja) | 2008-02-08 | 2015-04-15 | アンブルックス, インコーポレイテッドAmbrx, Inc. | 修飾されているレプチンポリペプチドおよびそれらの使用 |
JP2012509862A (ja) * | 2008-11-25 | 2012-04-26 | ノヴォ・ノルディスク・アー/エス | 肥満の治療のためのペプチド |
US8647621B2 (en) | 2009-07-27 | 2014-02-11 | Fina Biosolutions, Llc | Method of producing protein-carbohydrate vaccines reduced in free carbohydrate |
JP6564539B1 (ja) * | 2018-09-14 | 2019-08-21 | 長瀬産業株式会社 | スルホン酸化合物によるペプチド精製方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444744A (en) | 1980-03-03 | 1984-04-24 | Goldenberg Milton David | Tumor localization and therapy with labeled antibodies to cell surface antigens |
US4622420A (en) | 1980-03-18 | 1986-11-11 | The Regents Of The University Of California | Chelating agents and method |
US4865835A (en) | 1982-06-02 | 1989-09-12 | Begent Richard H J | Diagnosis and treatment of tumors |
US4507466A (en) | 1983-01-07 | 1985-03-26 | The Dow Chemical Corporation | Dense star polymers having core, core branches, terminal groups |
JPS59215321A (ja) | 1983-05-23 | 1984-12-05 | Sumitomo Chem Co Ltd | 二官能性配位子化合物を結合した反応性高分子 |
US4707352A (en) | 1984-01-30 | 1987-11-17 | Enzo Biochem, Inc. | Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group |
US4652440A (en) | 1984-05-03 | 1987-03-24 | Paik Chang H | Method of stably radiolabeling antibodies with technetium and rhenium |
IL71947A (en) | 1984-05-29 | 1987-10-30 | Yeda Research And Dev Comp Ltd | Enzyme hydrazides and method for detection and determination of glycoconjugates |
US4659839A (en) | 1984-10-10 | 1987-04-21 | Mallinckrodt, Inc. | Coupling agents for radiolabeled antibody fragments |
US4918164A (en) | 1987-09-10 | 1990-04-17 | Oncogen | Tumor immunotherapy using anti-idiotypic antibodies |
US4678667A (en) | 1985-07-02 | 1987-07-07 | 501 Regents of the University of California | Macrocyclic bifunctional chelating agents |
GB8610551D0 (en) | 1986-04-30 | 1986-06-04 | Hoffmann La Roche | Polypeptide & protein derivatives |
IN165717B (de) | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
JPH0611290B2 (ja) | 1986-11-05 | 1994-02-16 | 住友ベークライト株式会社 | ポリビニルアルコ−ルゲルのγ線滅菌法 |
US4861581A (en) | 1986-12-05 | 1989-08-29 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
US5084266A (en) | 1988-02-03 | 1992-01-28 | The University Of Melbourne | Method for tumor imaging utilizing a labelled tumor specific antibody and a non-tumor reactive antibody |
US4857599A (en) | 1988-02-08 | 1989-08-15 | The Dow Chemical Company | Modified dense star polymers |
GB8820377D0 (en) | 1988-08-26 | 1988-09-28 | Offord R E | Chemical compounds |
GB9004538D0 (en) * | 1990-02-28 | 1990-04-25 | Offord Robin E | Chemical compounds |
US5011676A (en) | 1990-03-27 | 1991-04-30 | Thomas Jefferson University | Method to directly radiolabel antibodies for diagnostic imaging and therapy |
AU8730691A (en) * | 1990-09-28 | 1992-04-28 | Neorx Corporation | Polymeric carriers for release of covalently linked agents |
GB9102450D0 (en) | 1991-02-05 | 1991-03-20 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5272253A (en) * | 1991-07-01 | 1993-12-21 | Eli Lilly And Company | Cluster conjugates of drugs with antibodies |
US6001364A (en) * | 1993-05-05 | 1999-12-14 | Gryphon Sciences | Hetero-polyoxime compounds and their preparation by parallel assembly |
WO1994025071A1 (en) | 1993-05-05 | 1994-11-10 | Keith Rose | Polyoxime compounds and their preparation |
US6174530B1 (en) * | 1993-05-05 | 2001-01-16 | Gryphon Sciences | Homogeneous polyoxime compositions and their preparation by parallel assembly |
-
1994
- 1994-05-05 AT AT94913192T patent/ATE191148T1/de not_active IP Right Cessation
- 1994-05-05 JP JP52408094A patent/JP3734828B2/ja not_active Expired - Fee Related
- 1994-05-05 CA CA002162157A patent/CA2162157A1/en not_active Abandoned
- 1994-05-05 EP EP94913192A patent/EP0697891B1/de not_active Expired - Lifetime
- 1994-05-05 DK DK94913192T patent/DK0697891T3/da active
- 1994-05-05 AU AU65438/94A patent/AU686153B2/en not_active Ceased
- 1994-05-05 PT PT94913192T patent/PT697891E/pt unknown
- 1994-05-05 ES ES94913192T patent/ES2146649T3/es not_active Expired - Lifetime
- 1994-05-05 DE DE69423753T patent/DE69423753T2/de not_active Expired - Fee Related
-
2000
- 2000-06-15 GR GR20000401389T patent/GR3033699T3/el not_active IP Right Cessation
- 2000-08-04 US US09/633,269 patent/US6663869B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK0697891T3 (da) | 2000-09-04 |
US6663869B1 (en) | 2003-12-16 |
AU6543894A (en) | 1994-11-21 |
EP0697891A1 (de) | 1996-02-28 |
DE69423753T2 (de) | 2000-11-02 |
JP3734828B2 (ja) | 2006-01-11 |
AU686153B2 (en) | 1998-02-05 |
PT697891E (pt) | 2000-09-29 |
EP0697891B1 (de) | 2000-03-29 |
ATE191148T1 (de) | 2000-04-15 |
ES2146649T3 (es) | 2000-08-16 |
JPH08510210A (ja) | 1996-10-29 |
CA2162157A1 (en) | 1994-11-10 |
GR3033699T3 (en) | 2000-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69423753D1 (de) | Polyoximverbindungen und deren herstellung | |
ES2141610T3 (es) | Compuestos con atomos espiranicos y su uso como materiales electroluminiscentes. | |
BR8504463A (pt) | Resina quimicamente endurecivel,processo para sua preparacao,misturas de compostos e misturas endurecidas de compostos | |
DK392084D0 (da) | Haerdelige materialer | |
PT98169A (pt) | Processo para a preparacao de analogos de oligonucleotidos com ligacoes internucleotido 3'-3' ou 5'-5' terminais | |
EP1004936A4 (de) | Resistharz, resistharzzusammensetzung und diese verwendendes verfahren zur herstellung von mustern | |
KR960007722A (ko) | 전도성 측쇄형 액정화합물 및 이를 사용한 배향막 | |
DE59303552D1 (de) | Modifiziertes Chlorhexidin-Addukt | |
CA2133885A1 (en) | Crystalline inclusion complex of diclofenac with beta-cyclodextrin | |
CA2032669A1 (en) | Process for incorporating o-hydroxyphenyl-s-triazines in organic polymers | |
AU583624B2 (en) | Polymers with pendant isocyanatocarbonyl groups, and their production processes, and compositions comprising them | |
BR9810210A (pt) | Melhoramentos em ou referentes a composiçõespoliméricas | |
ES2103194B1 (es) | Colorantes reactivos de aluminio-ftalocianina. | |
KR910004748A (ko) | 경화형 조성물 | |
BR9910099A (pt) | Método para melhorar a aparência em revestimentos compósitos de cor extrabrilho, e composições para o uso no mesmo | |
ATE178346T1 (de) | Verbesserte zusammensetzungen von bitumen, ihren verfahren zur herstellung und ihre anwendungen | |
MX9408333A (es) | Colorantes de dizaso de la serie estilbeno y procedimiento para su produccion. | |
ATE71103T1 (de) | Organische phosphor-macroringe, verfahren zu ihrer herstellung und ihre verwendungen. | |
DE68928684D1 (de) | Supraleiter und Verfahren zu deren Herstellung | |
JPS6420226A (en) | Production of modified epoxy resin | |
KR890011600A (ko) | 세포증식 억제성 안트라사이클린 항생제의 안정화된 건식 제제 및 이의 제조방법 | |
KR900014467A (ko) | 폴리아미드수지와 그의 제조방법 | |
ATE152715T1 (de) | Verfahren zur herstellung von norambreinolid | |
YEN | International Conference on Luminescence[Final Technical Digest Report] | |
Tesi et al. | Physical characteristics of substrate based on beech leaf and sphagnum peat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |